Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Connectome | 31 | 2022 | 88 | 5.300 |
Why?
|
| White Matter | 21 | 2021 | 90 | 4.100 |
Why?
|
| Nerve Net | 23 | 2021 | 112 | 4.050 |
Why?
|
| Brain Neoplasms | 21 | 2021 | 313 | 3.810 |
Why?
|
| Neural Pathways | 33 | 2022 | 122 | 2.130 |
Why?
|
| Diffusion Tensor Imaging | 31 | 2021 | 79 | 2.090 |
Why?
|
| Occipital Lobe | 9 | 2021 | 21 | 1.960 |
Why?
|
| Neurosurgical Procedures | 12 | 2020 | 231 | 1.860 |
Why?
|
| Magnetic Resonance Imaging | 34 | 2022 | 843 | 1.810 |
Why?
|
| Glioma | 8 | 2019 | 122 | 1.610 |
Why?
|
| Craniotomy | 11 | 2021 | 61 | 1.500 |
Why?
|
| Temporal Lobe | 6 | 2021 | 33 | 1.310 |
Why?
|
| Frontal Lobe | 7 | 2022 | 43 | 1.240 |
Why?
|
| Retrospective Studies | 27 | 2025 | 2638 | 1.230 |
Why?
|
| Humans | 86 | 2025 | 28906 | 1.150 |
Why?
|
| Deep Brain Stimulation | 3 | 2024 | 11 | 1.140 |
Why?
|
| Postoperative Complications | 10 | 2025 | 634 | 1.070 |
Why?
|
| Neuroimaging | 19 | 2018 | 88 | 1.000 |
Why?
|
| Heller Myotomy | 1 | 2025 | 1 | 0.950 |
Why?
|
| Myotomy | 1 | 2025 | 5 | 0.940 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2025 | 9 | 0.940 |
Why?
|
| Esophageal Achalasia | 1 | 2025 | 6 | 0.940 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2022 | 26 | 0.860 |
Why?
|
| Hydrocephalus | 2 | 2022 | 55 | 0.830 |
Why?
|
| Motor Cortex | 5 | 2021 | 48 | 0.790 |
Why?
|
| Middle Aged | 27 | 2025 | 7419 | 0.730 |
Why?
|
| Prefrontal Cortex | 5 | 2021 | 80 | 0.730 |
Why?
|
| Adult | 30 | 2025 | 8037 | 0.730 |
Why?
|
| Aged | 22 | 2025 | 5604 | 0.710 |
Why?
|
| Parietal Lobe | 7 | 2021 | 27 | 0.700 |
Why?
|
| Functional Neuroimaging | 2 | 2020 | 23 | 0.700 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2021 | 4 | 0.690 |
Why?
|
| Male | 38 | 2025 | 13946 | 0.680 |
Why?
|
| Laser Therapy | 1 | 2020 | 30 | 0.670 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2020 | 7 | 0.660 |
Why?
|
| Functional Laterality | 5 | 2021 | 64 | 0.650 |
Why?
|
| Nerve Fibers | 8 | 2018 | 53 | 0.620 |
Why?
|
| Rest | 1 | 2020 | 96 | 0.620 |
Why?
|
| Female | 35 | 2025 | 15649 | 0.600 |
Why?
|
| Meningioma | 5 | 2019 | 79 | 0.590 |
Why?
|
| Astrocytoma | 4 | 2020 | 37 | 0.580 |
Why?
|
| Arterial Pressure | 1 | 2018 | 9 | 0.580 |
Why?
|
| Terminal Care | 1 | 2018 | 43 | 0.540 |
Why?
|
| Gyrus Cinguli | 5 | 2022 | 33 | 0.530 |
Why?
|
| Cauda Equina | 2 | 2016 | 5 | 0.520 |
Why?
|
| Treatment Outcome | 11 | 2025 | 2426 | 0.510 |
Why?
|
| Meningeal Neoplasms | 5 | 2019 | 73 | 0.490 |
Why?
|
| Ganglia | 1 | 2016 | 9 | 0.490 |
Why?
|
| Choristoma | 1 | 2016 | 7 | 0.480 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2016 | 18 | 0.480 |
Why?
|
| Low Back Pain | 1 | 2016 | 29 | 0.480 |
Why?
|
| Hypertension | 1 | 2018 | 309 | 0.470 |
Why?
|
| Salvage Therapy | 2 | 2025 | 37 | 0.470 |
Why?
|
| Follow-Up Studies | 9 | 2025 | 1032 | 0.450 |
Why?
|
| Seizures | 3 | 2017 | 49 | 0.360 |
Why?
|
| Brain | 5 | 2024 | 770 | 0.360 |
Why?
|
| Wakefulness | 4 | 2019 | 25 | 0.350 |
Why?
|
| Electroencephalography | 2 | 2024 | 143 | 0.350 |
Why?
|
| Cerebral Cortex | 3 | 2022 | 136 | 0.340 |
Why?
|
| Young Adult | 9 | 2025 | 2841 | 0.340 |
Why?
|
| Suicide, Attempted | 2 | 2021 | 12 | 0.330 |
Why?
|
| Stereotaxic Techniques | 2 | 2020 | 14 | 0.330 |
Why?
|
| Brain Mapping | 9 | 2022 | 207 | 0.320 |
Why?
|
| Preoperative Care | 2 | 2020 | 81 | 0.320 |
Why?
|
| Neuronavigation | 2 | 2022 | 13 | 0.310 |
Why?
|
| Cerebrum | 2 | 2019 | 14 | 0.300 |
Why?
|
| Catheters | 2 | 2022 | 24 | 0.300 |
Why?
|
| Attention | 2 | 2019 | 91 | 0.290 |
Why?
|
| Corpus Callosum | 2 | 2019 | 20 | 0.290 |
Why?
|
| Electrodes, Implanted | 3 | 2024 | 41 | 0.290 |
Why?
|
| Reoperation | 3 | 2025 | 153 | 0.280 |
Why?
|
| Vertebral Artery | 2 | 2018 | 16 | 0.280 |
Why?
|
| Treatment Failure | 2 | 2025 | 73 | 0.270 |
Why?
|
| Neoplasms, Neuroepithelial | 2 | 2018 | 9 | 0.260 |
Why?
|
| Esophagoplasty | 1 | 2025 | 1 | 0.240 |
Why?
|
| Esophagectomy | 1 | 2025 | 10 | 0.240 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 2025 | 1 | 0.230 |
Why?
|
| Duodenostomy | 1 | 2025 | 2 | 0.230 |
Why?
|
| Jejunostomy | 1 | 2025 | 5 | 0.230 |
Why?
|
| Propensity Score | 1 | 2025 | 59 | 0.230 |
Why?
|
| Esophageal Neoplasms | 1 | 2025 | 33 | 0.230 |
Why?
|
| Duodenum | 1 | 2025 | 18 | 0.230 |
Why?
|
| Time-to-Treatment | 1 | 2025 | 33 | 0.230 |
Why?
|
| Esophagus | 1 | 2025 | 72 | 0.220 |
Why?
|
| Referral and Consultation | 1 | 2025 | 98 | 0.220 |
Why?
|
| Recurrence | 1 | 2025 | 327 | 0.220 |
Why?
|
| Colon | 1 | 2025 | 123 | 0.220 |
Why?
|
| Time Factors | 2 | 2025 | 1615 | 0.220 |
Why?
|
| Electric Power Supplies | 1 | 2024 | 3 | 0.210 |
Why?
|
| Epilepsy | 1 | 2024 | 37 | 0.210 |
Why?
|
| Adolescent | 7 | 2019 | 3198 | 0.210 |
Why?
|
| Laparoscopy | 1 | 2025 | 156 | 0.200 |
Why?
|
| Neoplasm Grading | 3 | 2018 | 105 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 22 | 0.200 |
Why?
|
| Thalamus | 2 | 2020 | 27 | 0.190 |
Why?
|
| Child | 6 | 2019 | 2292 | 0.190 |
Why?
|
| Basal Ganglia | 2 | 2019 | 10 | 0.190 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 2065 | 0.190 |
Why?
|
| Child, Preschool | 4 | 2019 | 1174 | 0.190 |
Why?
|
| Cadaver | 5 | 2020 | 61 | 0.190 |
Why?
|
| Neurosurgeons | 1 | 2022 | 22 | 0.180 |
Why?
|
| Neurovascular Coupling | 1 | 2024 | 154 | 0.180 |
Why?
|
| Cerebellar Neoplasms | 2 | 2019 | 30 | 0.180 |
Why?
|
| Skull Fractures | 2 | 2018 | 19 | 0.180 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 2 | 2019 | 10 | 0.180 |
Why?
|
| Firearms | 1 | 2021 | 5 | 0.180 |
Why?
|
| Semantic Web | 1 | 2021 | 1 | 0.170 |
Why?
|
| Enoxaparin | 1 | 2021 | 38 | 0.170 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2020 | 33 | 0.170 |
Why?
|
| Neck Injuries | 2 | 2018 | 6 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2020 | 2 | 0.170 |
Why?
|
| Apraxias | 1 | 2020 | 2 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2020 | 347 | 0.170 |
Why?
|
| Lasers | 1 | 2020 | 68 | 0.170 |
Why?
|
| Electrocorticography | 1 | 2020 | 6 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 98 | 0.160 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 51 | 0.160 |
Why?
|
| Cerebral Peduncle | 1 | 2020 | 3 | 0.160 |
Why?
|
| Eyebrows | 1 | 2020 | 3 | 0.160 |
Why?
|
| Statistics as Topic | 1 | 2020 | 79 | 0.160 |
Why?
|
| Movement | 1 | 2021 | 100 | 0.160 |
Why?
|
| Brain Stem Neoplasms | 1 | 2020 | 12 | 0.160 |
Why?
|
| Magnetoencephalography | 1 | 2020 | 28 | 0.160 |
Why?
|
| Carbidopa | 1 | 2019 | 3 | 0.160 |
Why?
|
| Levodopa | 1 | 2019 | 11 | 0.160 |
Why?
|
| Methylphenidate | 1 | 2019 | 8 | 0.160 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 483 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 130 | 0.160 |
Why?
|
| Visual Cortex | 1 | 2019 | 8 | 0.160 |
Why?
|
| Cause of Death | 1 | 2019 | 73 | 0.160 |
Why?
|
| Brain Edema | 1 | 2019 | 21 | 0.150 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 123 | 0.150 |
Why?
|
| Hippocampus | 1 | 2021 | 198 | 0.150 |
Why?
|
| Cerebral Aqueduct | 1 | 2019 | 4 | 0.150 |
Why?
|
| Inferior Colliculi | 1 | 2019 | 4 | 0.150 |
Why?
|
| Hemangioblastoma | 1 | 2019 | 12 | 0.150 |
Why?
|
| Monitoring, Intraoperative | 2 | 2016 | 30 | 0.150 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 16 | 0.150 |
Why?
|
| Aphasia | 1 | 2019 | 5 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2019 | 23 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2021 | 297 | 0.150 |
Why?
|
| Sensorimotor Cortex | 1 | 2018 | 7 | 0.150 |
Why?
|
| Occipital Bone | 1 | 2018 | 10 | 0.150 |
Why?
|
| Models, Theoretical | 1 | 2019 | 134 | 0.150 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 54 | 0.150 |
Why?
|
| Language | 1 | 2019 | 65 | 0.150 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 35 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 122 | 0.140 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 63 | 0.140 |
Why?
|
| Dura Mater | 1 | 2018 | 11 | 0.140 |
Why?
|
| Radiosurgery | 1 | 2019 | 84 | 0.140 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 26 | 0.140 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 52 | 0.140 |
Why?
|
| Skull Base | 1 | 2018 | 35 | 0.140 |
Why?
|
| Hospitals | 1 | 2018 | 77 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2018 | 36 | 0.140 |
Why?
|
| Psychosurgery | 1 | 2017 | 3 | 0.140 |
Why?
|
| Neurologists | 1 | 2017 | 5 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 481 | 0.140 |
Why?
|
| Homosexuality, Male | 1 | 2017 | 17 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2018 | 357 | 0.130 |
Why?
|
| United States | 2 | 2021 | 2226 | 0.130 |
Why?
|
| Equipment Failure Analysis | 1 | 2017 | 38 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 225 | 0.130 |
Why?
|
| Schizophrenia | 1 | 2017 | 51 | 0.130 |
Why?
|
| Abdomen | 1 | 2017 | 41 | 0.130 |
Why?
|
| Glioblastoma | 1 | 2018 | 109 | 0.130 |
Why?
|
| Spinal Fractures | 1 | 2017 | 44 | 0.130 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 81 | 0.130 |
Why?
|
| Decision Making | 1 | 2018 | 179 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2017 | 222 | 0.120 |
Why?
|
| Oligodendroglioma | 1 | 2016 | 13 | 0.120 |
Why?
|
| Headache | 1 | 2016 | 34 | 0.120 |
Why?
|
| Cerebral Ventricles | 1 | 2015 | 17 | 0.120 |
Why?
|
| Laminectomy | 1 | 2016 | 31 | 0.120 |
Why?
|
| Arachnoid Cysts | 1 | 2015 | 4 | 0.120 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 22 | 0.120 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2015 | 19 | 0.120 |
Why?
|
| Ganglioglioma | 1 | 2015 | 4 | 0.120 |
Why?
|
| Neural Tube Defects | 1 | 2015 | 20 | 0.120 |
Why?
|
| Dissection | 3 | 2020 | 20 | 0.110 |
Why?
|
| Spinal Cord Diseases | 1 | 2015 | 33 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 129 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 379 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 254 | 0.090 |
Why?
|
| Prognosis | 2 | 2025 | 811 | 0.070 |
Why?
|
| Infant | 3 | 2017 | 1026 | 0.070 |
Why?
|
| Pyramidal Tracts | 2 | 2017 | 8 | 0.070 |
Why?
|
| Mastectomy | 1 | 2025 | 22 | 0.060 |
Why?
|
| Enteral Nutrition | 1 | 2025 | 23 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2024 | 75 | 0.050 |
Why?
|
| Risk Factors | 2 | 2019 | 2129 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 787 | 0.040 |
Why?
|
| Hong Kong | 1 | 2021 | 3 | 0.040 |
Why?
|
| Speech | 1 | 2021 | 13 | 0.040 |
Why?
|
| Semantics | 1 | 2021 | 11 | 0.040 |
Why?
|
| Models, Anatomic | 1 | 2021 | 25 | 0.040 |
Why?
|
| Hand | 1 | 2021 | 26 | 0.040 |
Why?
|
| Research | 1 | 2021 | 93 | 0.040 |
Why?
|
| Movement Disorders | 1 | 2020 | 4 | 0.040 |
Why?
|
| Subthalamic Nucleus | 1 | 2020 | 3 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2019 | 50 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 68 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 50 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 469 | 0.040 |
Why?
|
| Language Disorders | 1 | 2019 | 3 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 26 | 0.040 |
Why?
|
| Patient Participation | 1 | 2019 | 58 | 0.040 |
Why?
|
| Cerebellum | 1 | 2019 | 41 | 0.040 |
Why?
|
| Hemangiopericytoma | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2018 | 14 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 2018 | 28 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 110 | 0.030 |
Why?
|
| Syndrome | 1 | 2018 | 79 | 0.030 |
Why?
|
| Skull Base Neoplasms | 1 | 2018 | 22 | 0.030 |
Why?
|
| Titanium | 1 | 2018 | 37 | 0.030 |
Why?
|
| Microsurgery | 1 | 2018 | 50 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 739 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 236 | 0.030 |
Why?
|
| Brain Stem | 1 | 2017 | 23 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 479 | 0.030 |
Why?
|
| Equipment Design | 1 | 2018 | 218 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2017 | 84 | 0.030 |
Why?
|
| Angiography | 1 | 2017 | 35 | 0.030 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2017 | 17 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 897 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 273 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 138 | 0.030 |
Why?
|
| Karnofsky Performance Status | 1 | 2016 | 15 | 0.030 |
Why?
|
| World Health Organization | 1 | 2016 | 13 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 194 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2016 | 15 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 302 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 432 | 0.030 |
Why?
|
| PubMed | 1 | 2015 | 8 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 14 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 111 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2017 | 916 | 0.030 |
Why?
|